The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with ...

The Iowa State University Extension and Outreach Dairy Team monthly webinar will discuss extra-label drug use.

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

Senate Republicans on Wednesday passed legislation that would enable patients to force hospitals into administering drugs for off-label use if the hospital’s own physicians refuse. The legislation ...

The U.S. Food and Drug Administration and the U.S. Department of Agriculture  have announced a joint request for Information ...

A dairy state Senator remains critical of the Food and Drug Administration for failing to enforce dairy labeling standards.

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

The agencies seek information on industry practices and preferences for date labeling, research results on consumer ...